# Vedolizumab Monotherapy Vs Combination Therapy With Tacrolimus in UC

> **NCT02954159** · PHASE3 · TERMINATED · sponsor: **Medical College of Wisconsin** · enrollment: 4 (actual)

## Conditions studied

- Ulcerative Colitis

## Interventions

- **DRUG:** Tacrolimus
- **DRUG:** Vedolizumab
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02954159
- **Lead sponsor:** Medical College of Wisconsin
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-05-18
- **Primary completion:** 2019-01-31
- **Final completion:** 2019-01-31
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** insufficient enrollment
- **Last updated:** 2020-09-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02954159

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02954159, "Vedolizumab Monotherapy Vs Combination Therapy With Tacrolimus in UC". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02954159. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*